| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/31/2001 | EP1071437A1 Streptococcus preparation |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071417A1 Use of cannabinoids as anti-inflammatory agents |
| 01/31/2001 | EP1071405A1 Method for the treatment of asthma |
| 01/31/2001 | EP0799054B1 Conjugate for treating inflammatory diseases |
| 01/31/2001 | EP0768884B1 Drugs containing a synergistic mixture of metronidazole and clindamycin |
| 01/31/2001 | CN1282330A Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels |
| 01/31/2001 | CN1282254A Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 01/31/2001 | CN1282253A Small peptides and method for treatment of asthma and inflammation |
| 01/31/2001 | CN1282223A Fat blend |
| 01/31/2001 | CN1281724A Yantongzhi medicine for curing tooth-ache |
| 01/31/2001 | CN1061257C Chinese patent drug for curing rheumatoid disease and preparing method thereof |
| 01/30/2001 | US6180781 Process for making mometasone furoate monohydrate |
| 01/30/2001 | US6180676 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/30/2001 | US6180675 IL-8 receptor antagonists |
| 01/30/2001 | US6180671 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
| 01/30/2001 | US6180662 Mixture of cinnamic acid, antioxidant, enzyme, microbiocides and viricides |
| 01/30/2001 | US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180645 Antiepilepic agent |
| 01/30/2001 | US6180644 Immunotherapeutic agents |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180637 Therapy for parkinson, alzheimer disease |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/25/2001 | WO2001006262A1 Diagnostics and therapeutics for macular degeneration |
| 01/25/2001 | WO2001006018A1 Antisense modulation of map kinase kinase 6 expression |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005958A1 Antisense modulation of p13 kinase p110 delta expression |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005810A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 01/25/2001 | WO2001005792A1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005789A1 TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005782A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005774A1 Heteroaromatic ring compounds |
| 01/25/2001 | WO2001005761A1 sPLA2 INHIBITORS |
| 01/25/2001 | WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 01/25/2001 | WO2001005753A1 Diacylhydrazine derivatives |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005745A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005744A1 Novel aminobenzophenones |
| 01/25/2001 | WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | WO2001005420A1 Small peptides and methods for downregulation of ige |
| 01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
| 01/25/2001 | WO2001005397A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | WO2001005395A1 Selective inhibition of cyclooxygenase-2 |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005381A1 Percutaneously absorbable preparations |
| 01/25/2001 | WO2000066111B1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/25/2001 | WO2000061171A3 Uses of mammalian ox2 protein and related reagents |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000056356A3 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives |
| 01/25/2001 | CA2381961A1 Splice variants of cd40-receptor |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379489A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2379336A1 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | CA2379323A1 Small peptides and methods for downregulation of ige |
| 01/25/2001 | CA2379319A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379316A1 Novel aminobenzophenones |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379286A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379208A1 Spla2 inhibitors |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2379041A1 Diacylhydrazine derivatives |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2378084A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377527A1 Heteroaromatic ring compounds |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |